{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T23:12:20Z","timestamp":1747177940921,"version":"3.40.5"},"reference-count":14,"publisher":"Informa UK Limited","issue":"10","funder":[{"name":"ClinicalTrials.gov identifier","award":["NCT03961672"],"award-info":[{"award-number":["NCT03961672"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2024,8,23]]},"DOI":"10.1080\/10428194.2024.2361841","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T08:44:29Z","timestamp":1717577069000},"page":"1516-1519","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["A phase II study of induction followed by intermittent duvelisib dosing in patients with chronic lymphocytic leukemia\/small lymphocytic lymphoma (CLL\/SLL)"],"prefix":"10.1080","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7917-5713","authenticated-orcid":false,"given":"Geoffrey","family":"Shouse","sequence":"first","affiliation":[{"name":"City of Hope National Medical Center, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[{"name":"City of Hope National Medical Center, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Siddiqi","sequence":"additional","affiliation":[{"name":"City of Hope National Medical Center, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Muir","sequence":"additional","affiliation":[{"name":"City of Hope National Medical Center, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R.","family":"Brown","sequence":"additional","affiliation":[{"name":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen E.","family":"Spurgeon","sequence":"additional","affiliation":[{"name":"The Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey V.","family":"Danilov","sequence":"additional","affiliation":[{"name":"City of Hope National Medical Center, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,6,5]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000871"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-05-850461"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3061"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18053"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx289"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001795"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00145-5"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.13000"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-806398"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-786566"},{"key":"e_1_3_3_12_1","unstructured":"Administration. UFaD. FDA warns about possible increased risk of death and serious side effects with cancer drug copiktra (duvelisib). 2022. https:\/\/www.fda.gov\/drugs\/fda-drug-safety-podcasts\/fda-warns-about-possible-increased-risk-death-and-serious-side-effects-cancer-drug-copiktra"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2300696"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx031"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-165409"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2024.2361841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T07:28:42Z","timestamp":1727767722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2024.2361841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,5]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,8,23]]}},"alternative-id":["10.1080\/10428194.2024.2361841"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2024.2361841","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"type":"print","value":"1042-8194"},{"type":"electronic","value":"1029-2403"}],"subject":[],"published":{"date-parts":[[2024,6,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-04-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}